Regional Health Headlines
Today is September 24, 2024. All times in Eastern Daylight Time.
Marinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst Day
09/20/2024 - 08:00 AM
Merck Receives Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Regimens as Treatment for Patients With Two Types of Gynecologic Cancers
09/20/2024 - 07:30 AM
Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting
09/19/2024 - 12:31 PM
Truveris Collaborates With Mark Cuban Cost Plus Drug Company to Reduce Pharmacy Benefits Spend
09/19/2024 - 08:30 AM
Zoetis to Host Webcast and Conference Call on Third Quarter 2024 Financial Results
09/19/2024 - 08:30 AM
Alto Pharmacy Expands Same Day Courier Home Delivery to Serve Fertility Patients in Philadelphia, San Antonio and Colorado Springs
09/19/2024 - 08:00 AM
Vytala Inc Debuts With Initial Close of Pre-Seed Financing to End Nutrient Deficiencies in Patients With Digestive Disorders
09/19/2024 - 07:00 AM
New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption
09/19/2024 - 06:48 AM
Truliant Consulting launches a white paper on Artificial Intelligence in Pharmacovigilance
09/19/2024 - 06:38 AM
Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)
09/18/2024 - 05:21 PM
FIGS Expands its Retail Footprint to the East Coast with the Opening of its Second Community Hub
09/18/2024 - 09:00 AM
From Burnout to Breakthrough: The C-Suite Renewal Workshop
09/18/2024 - 09:00 AM
IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment
09/18/2024 - 08:00 AM
Blue Matter Acquires Sam Brown Inc., a Leading Healthcare Corporate Communications and Public Relations Agency
09/18/2024 - 08:00 AM
Crossroads Treatment Centers Expands Instant Intake® to Simplify Access to Substance Use Disorder Treatment
09/18/2024 - 08:00 AM
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
09/18/2024 - 07:30 AM
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
09/18/2024 - 07:00 AM
FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis
09/18/2024 - 07:00 AM
New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis
09/18/2024 - 06:59 AM
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)
09/18/2024 - 06:45 AM
US Consumers and Healthcare Professionals at Odds on Healthcare Technology According to New RXNT Study
09/17/2024 - 12:37 PM
AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem
09/17/2024 - 12:20 PM
Infinity Bio Unveils the World’s Most Comprehensive Autoantibody Analysis Service: HuSIGHT-Total™
09/17/2024 - 12:07 PM
Summit Health Opens Two New Multispecialty Healthcare Facilities in Fair Lawn and Bridgewater, N.J.
09/17/2024 - 11:41 AM
Sapio Sciences Partner Program Welcomes Astrix
09/17/2024 - 09:06 AM
1
2
3
« Previous
Next »
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire
News
Industry News
News
Delaware Bio Observer
Press Releases
Featured Member
Delaware Bio Partners
Industry News